M&A Advisor for Healthcare IT and Health Tech SaaS Companies

733Park advises healthcare IT and health tech SaaS companies on sales and acquisitions. Engagements are senior-led by Lane Gordon and focused on companies with $5M to $350M in enterprise value.

Founders searching for an M&A advisor for healthcare IT and health tech SaaS companies are usually dealing with a specific tension. Healthcare software commands strong buyer interest, but the diligence is heavier than in almost any other vertical, and buyers punish sellers who show up unprepared. The right advisor knows both sides of that equation.

Who buys healthcare IT companies

Four buyer groups account for most of the activity. EHR platforms buy to extend their footprint across the clinical and administrative workflow, and to keep third parties from owning valuable adjacencies. Payers buy technology that lowers cost of care, improves member experience, or gives them better data. PE-backed platforms are among the most consistent acquirers in the category, rolling up point solutions into broader suites for providers, payers, or both. And strategics from adjacent markets, including revenue cycle, payments, and vertical SaaS companies, buy healthcare IT to enter or expand in the space.

The same company can be worth meaningfully different amounts to each of these buyers. Process design, meaning which buyers you approach, in what order, with what story, is where an advisor earns the fee.

What drives value in a health tech SaaS sale

Recurring revenue with strong retention is the foundation, as in any SaaS deal. On top of that, healthcare buyers pay for integrations. Live, bidirectional connections to EHRs, clearinghouses, and payer systems take years to build and certify, and they function as a moat. Compliance is the third pillar. HIPAA posture, security certifications, and clean data-handling practices are table stakes, and gaps surface in diligence as price reductions or escrow demands.

The fourth driver is stickiness with payers and providers. Healthcare organizations are slow to adopt and slower to rip out. If your product is embedded in clinical or billing workflows, your churn profile reflects it, and buyers will pay for that durability.

The patient payments angle

One of the strongest theses in healthcare IT right now sits at the intersection of software and money movement. Patient responsibility keeps growing as a share of provider revenue, and software that handles patient payments, billing, and collections is strategic to providers and acquirers alike. This is where 733Park's background is directly relevant. We have spent 25 years in payments M&A, with comparable depth in fintech, vertical SaaS, and AI. If your healthcare IT company touches patient payments, revenue cycle, or embedded billing, we know the buyers who care about that capability and how they value it, because many of them are payments acquirers we have worked across for years.

How we work

733Park has facilitated more than $10 billion in transaction volume across 209+ deals. Most engagements close within four to six months from kickoff. You work directly with Lane Gordon through positioning, buyer outreach, negotiation, and close. No junior associates running your deal. We handle sell-side and buy-side mandates, and we consult on growth strategy and exit readiness for founders planning a sale one to two years out. In healthcare IT, that preparation window matters more than in most verticals, because compliance documentation and integration evidence take time to assemble properly.

If you are weighing a sale of your healthcare IT or health tech SaaS company, the first step is understanding what buyers would pay today and what would move that number. Start with a confidential conversation at 733park.com/contact or get a baseline from our free valuation calculator at 733park.com/tools/portfolio-valuation.